WHO Classifies Omicron as COVID-19 Variant of Concern Amid Unknowns
The World Health Organization officially designates the B.1.1.529 mutation, known as Omicron, as a variant of concern due to its high number of mutations. Scientists are still working to determine its transmissibility, severity, and impact on vaccines.
The World Health Organization officially designates the B.1.1.529 mutation, known as Omicron, as a COVID-19 variant of concern based on evidence that its numerous mutations may affect how the virus spreads and impacts human health. Researchers in South Africa and globally are actively conducting studies to understand the full scope of this new variant.
Scientists do not yet know if Omicron is more transmissible than other variants like Delta, despite rising positive test rates in affected South African regions. Additionally, it remains unclear if Omicron causes more severe disease, as preliminary hospitalization increases may simply reflect a higher overall number of infections rather than intrinsically more dangerous symptoms.
Early evidence suggests there is an increased risk of reinfection for individuals who have already recovered from COVID-19, though data remains limited. The WHO is actively collaborating with technical partners to evaluate how this variant impacts the effectiveness of existing vaccines and other established countermeasures.